A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

NCT04433585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: LY3471851
DRUG: Placebo

Sponsor

Nektar Therapeutics

Collaborators

[object Object]